240 related articles for article (PubMed ID: 15547629)
21. Conventional treatments of localized prostate cancer.
Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
[TBL] [Abstract][Full Text] [Related]
22. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study.
Hoffman RM; Barry MJ; Stanford JL; Hamilton AS; Hunt WC; Collins MM
Am J Med; 2006 May; 119(5):418-25. PubMed ID: 16651054
[TBL] [Abstract][Full Text] [Related]
23. Early outcomes of active surveillance for localized prostate cancer.
Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
[TBL] [Abstract][Full Text] [Related]
24. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer.
Liu L; Coker AL; Du XL; Cormier JN; Ford CE; Fang S
J Surg Oncol; 2008 Jun; 97(7):583-91. PubMed ID: 18381603
[TBL] [Abstract][Full Text] [Related]
25. Re: Prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial.
Schulz RJ; Kagan AR
J Natl Cancer Inst; 2009 Jan; 101(2):124. PubMed ID: 19141784
[No Abstract] [Full Text] [Related]
26. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
27. Geographic and socioeconomic variation in the treatment of prostate cancer.
Krupski TL; Kwan L; Afifi AA; Litwin MS
J Clin Oncol; 2005 Nov; 23(31):7881-8. PubMed ID: 16204005
[TBL] [Abstract][Full Text] [Related]
28. [Practical management of localized prostate cancer: surveillance, surgery or radiotherapy].
Le Duc A
Rev Prat; 1994 Mar; 44(5):591-3. PubMed ID: 8066395
[TBL] [Abstract][Full Text] [Related]
29. Short- and long-term mortality with localized prostate cancer.
Merglen A; Schmidlin F; Fioretta G; Verkooijen HM; Rapiti E; Zanetti R; Miralbell R; Bouchardy C
Arch Intern Med; 2007 Oct; 167(18):1944-50. PubMed ID: 17923593
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life in Japanese men with localized prostate cancer: assessment with the SF-8.
Sugimoto M; Takegami M; Suzukamo Y; Fukuhara S; Kakehi Y
Int J Urol; 2008 Jun; 15(6):524-8. PubMed ID: 18422571
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer: epidemiology and health-related quality of life.
Penson DF; Rossignol M; Sartor AO; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S3-11. PubMed ID: 19095126
[TBL] [Abstract][Full Text] [Related]
32. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
[TBL] [Abstract][Full Text] [Related]
33. Management of prostate cancer. Part 2: localized and locally advanced disease.
Sooriakumaran P; Khaksar SJ; Shah J
Expert Rev Anticancer Ther; 2006 Apr; 6(4):595-603. PubMed ID: 16613546
[TBL] [Abstract][Full Text] [Related]
34. An Internet intervention for management of uncertainty during active surveillance for prostate cancer.
Kazer MW; Bailey DE; Sanda M; Colberg J; Kelly WK
Oncol Nurs Forum; 2011 Sep; 38(5):561-8. PubMed ID: 21875843
[TBL] [Abstract][Full Text] [Related]
35. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
[TBL] [Abstract][Full Text] [Related]
36. Expectant management for men with early stage prostate cancer.
Filson CP; Marks LS; Litwin MS
CA Cancer J Clin; 2015; 65(4):265-82. PubMed ID: 25958817
[TBL] [Abstract][Full Text] [Related]
37. Active surveillance with selective delayed intervention: walking the line between overtreatment for indolent disease and undertreatment for aggressive disease.
Klotz LH
Can J Urol; 2005 Feb; 12 Suppl 1():53-7; discussion 101-2. PubMed ID: 15780167
[TBL] [Abstract][Full Text] [Related]
38. Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis.
Klotz LH; Nam RK
Can J Urol; 2006 Feb; 13 Suppl 1():48-55. PubMed ID: 16526983
[TBL] [Abstract][Full Text] [Related]
39. Management of clinically localized prostate cancer by radical prostatectomy followed by watchful waiting.
Kirby R
Nat Clin Pract Urol; 2005 Jun; 2(6):298-303. PubMed ID: 16474812
[TBL] [Abstract][Full Text] [Related]
40. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]